D1 Capital Partners led the latest financing round totaling $30 million for Silicon Valley medical device company Sight Sciences.
Proceeds from the Series E Preferred Stock financing . . .
Continue Reading With a Free Trial
Unlock this article instantly, along with the rest of our premium content, newsletters and mandate charts.
Already a subscriber? Log in.